Browsing Category
Medicines for Covid-19
15 posts
Early Treatment with Pegylated Interferon Lambda for Covid-19 — [a “new” old drug (interferon) for the covid arsenal]
health and techinstitute Joaquim Cardoso MScFounder, Chief Researcher & EditorFebruary 9, 2023 ABSTRACT BACKGROUND METHODS RESULTS CONCLUSIONS (Funded by…
COVID drug Paxlovid was hailed as a game-changer. What happened? Which competition is coming?
the health strategist institute for continuous health transformation& digital health Joaquim Cardoso MScChief Researcher, Editor and Senior AdvisorJanuary…
A Valuable COVID Drug Doesn’t Work against New Variants [ bebtelovimab]
health transformationstrategy institute Joaquim Cardoso MScChief Researcher, Editor and Senior AdvisorJanuary3, 2023 Executive Summary [by the Editor of…
V116 Promising new Covid pill shows advantages over Paxlovid in trial [with 822 participants]
A Chinese antiviral pill was found to be as effective as Paxlovid in a Phase 3 trial, and…
Antiviral treatments lead to the rapid accrual of hundreds of SARS-CoV-2 mutations in immunocompromised patients [excerpt]
transforming health institute for continuous health transformation& digital health Joaquim Cardoso MScFounder and Chief Researcher & EditorDecember 25, 2022…
Merck antiviral trial shows promising impact on Covid recovery time – [though it did not prevent it ]
This is a republication of the article “Merck antiviral trial shows promising impact on Covid recovery time”, with…
The continued evolution of omicron variants reinforces the need for new therapeutic monoclonal antibodies for Covid-19 – remdesivir, molnupiravir, and nirmatrelvir are efficacious against both BQ.1.1 and XBB in vitro.
continuoustranformation4health research institute and advisory consulting Joaquim Cardoso MSc* Founder, and Chief Researcher & EditorDecember 9, 2022 This is…
Zinc for Patients with COVID-19? What is the evidence?
Health, Care and Tech Transformation (HCTT) research institute, knowledge portal andadvisory consulting Joaquim Cardoso MSc*Chief Researcher & Editor…
Is It the End of COVID-19 as We Know it? [are we in the Endemic Phase?]
Site editor: Joaquim Cardoso MSc.The Health Strategist — for continuous health transformationSeptember 23, 2022 Think Global Healthby Mary Brophy MarcusSeptember…
3 new pandemic strategies by 2 winners of the 2019 Nobel Prize in Economics.
1.Relying on population-wide vaccination is not working. 2.Other treatments seem more promising. 3.Rich countries must make smarter investments in…
